A Crohn’s Conundrum: Can the Faecal Calprotectin Level Act as a Sensitive Cut-off to Prevent Unnecessary MRI Small Bowel Scans?
Journal Title: Radiology – Open Journal - Year 2017, Vol 2, Issue 2
Abstract
Background: Current gastroenterology practice in evaluating those with diarrhoeal symptoms and a positive faecal calprotectin (CP) is to perform colonoscopy. Colonoscopy however is limited, in that it cannot exclude disease proximal to the terminal ileum. Therefore, for many patients not known to have Crohn’s disease, gastroenterologists are often concerned about the possibility of more proximal small bowel Crohn’s and request an magnetic resonance imaging (MRI) small bowel scan. Aims: This is the first study to investigate whether patients with a clinical suspicion of Crohn’s but with a normal colonoscopy will benefit from MRI in terms of diagnostic evaluation if they have a CP below the cut-off. Method: MRI small bowel reports, CP levels and colonoscopy reports were analysed (where obtainable) from 422 scans at a district general hospital in Stevenage, between 02/04/2015 and 21/07/2017. Eighty-five patients had features suggestive of Crohn’s but had normal colonoscopy findings. These were divided into those who had a CP above or below 600. Results: Within 55 patients who had a calprotectin below 600, we report that none (0%) of these patients were found to have significantly positive findings for Crohn’s on subsequent MRI. Amongst 30 patients with a positive CP, 8 (26.6%) were found to have active disease on MRI. The sensitivity of calprotectin was therefore identified to be 100% (95% CI 63.06% to 100%) and the specificity of the test was 71.43 % (95% CI 60% to 81.15%). Negative predictive value (NPV) was 1.00 and positive predictive value (PPV) was 0.27. Conclusion: Our study is the first to suggest that in patients with features of Crohn’s who have a normal colonoscopy, calprotectin performs impressively as a sensitive marker of the presence of small bowel inflammation on subsequent MRI. Further prospective studies would be needed to validate a potential approach of using the biomarker as a cut-off to reduce unnecessary MRI small bowel scans.
Authors and Affiliations
Faraz Hosseini-Ardehali
Keywords
Related Articles
- EP ID EP554412
- DOI 10.17140/ROJ-2-117
- Views 156
- Downloads 0
Two Case Reports of Angioleiomyoma of the Finger
Angioleiomyoma represents a benign stromal tumor, which usually occurs in the subcutaneous tissue of the extremities. The angioleiomyoma in the finger is rare. We report 2 rare cases of an angioleiomyoma in finger. Case...
Interoperability in Radiography Data: The Impossible Dream
Background: Technology in healthcare is changing at a very rapid pace. To ensure that technology is used efficiently to combat rising healthcare costs and new federal policies and laws, all technology must be able to com...
Cerebral Blood Flow Assessment by Digital Subtraction Angiography
Cerebral vascular disease is responsible for nearly 800 000 hospital admissions annually with a total healthcare cost of $34 billion. Neuro-interventional surgery is at the forefront of fast-response assessment and inter...
Will Plain Abdominal Radiographs become Obsolete?
Plain abdominal radiographs are often used as the first line investigation in diagnosing abdominal pathologies such as bowel obstruction and gastrointestinal perforation. However, their interpretation can often be non-sp...
Bio-Mathematical Modelling in Tumor Evaluation Via Magnetic Resonance Imaging
In the last 25 years, within the field of tumor evaluation using magnetic resonance imaging (MRI), 2 main promising applications have emerged that can provide useful functional information beyond the morphological images...